Concepedia

Publication | Open Access

1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon

DOIFull Paper Access

74

Citations

19

References

2021

Year

Ravish Sachar, Yoshimitsu Soga, Mohammad M. Ansari, Amane Kozuki, Louis Lopez, Marianne Brodmann, Herman Schroë, Vijay S. Ramanath, Juan Diaz‐Cartelle, Thomas Zeller
JACC: Cardiovascular Interventions

Abstract

The low-dose Ranger DCB demonstrated significantly better effectiveness than standard PTA through 1 year and a good safety profile. (Ranger™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty [RANGER II SFA]; NCT03064126).

References

YearCitations

Page 1